The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (Simcyp®) predicts in vivo metabolic inhibition.

Ashok Rakhit, Michael P. Pantze, Scott Fettner, Hannah M. Jones, Jean-Eric Charoin, Myriam Riek, Bert L. Lum, Marta Hamilton
January 1, 2008
Learn More
LinkedIn